3 of 3: According to Medtech Europe, SME's make up 90% of medical technology companies in Europe. A 2023 Finnish study indicated that around 45% of health technology companies are micro-enterprises (fewer than 10 persons, turnover <2 million Euros) (https://pmc.ncbi.nlm.nih.gov/articles/PMC10062684/).
Innovate Orthopaedics
Company · United Kingdom
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track Innovate in PolicySpeak: request access →
Work at Innovate Orthopaedics? so we know who speaks for it.
Their record over time
Innovate Orthopaedics filed 3 positions on 3 Oct 2025, across 1 of the 326 legislative files tracked here.
What they argued
2 of 3: According to Medtech Europe, SME's make up 90% of medical technology companies in Europe. A 2023 Finnish study indicated that around 45% of health technology companies are micro-enterprises (fewer than 10 persons, turnover <2 million Euros) (https://pmc.ncbi.nlm.nih.gov/articles/PMC10062684/).
1 of 3: According to Medtech Europe, SME's make up 90% of medical technology companies in Europe. A 2023 Finnish study indicated that around 45% of health technology companies are micro-enterprises (fewer than 10 persons, turnover <2 million Euros) (https://pmc.ncbi.nlm.nih.gov/articles/PMC10062684/).
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from Innovate Orthopaedics’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.